Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J T Welch

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Nature Medicine|September 6, 2000
Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosisO Zimhony, J S Cox, J T Welch, et al.
Carbohydrate Research|October 18, 1993
The synthesis of 2,3-dideoxy-2-fluoro-3-C-methylpentose-containing nucleosides via [3,3]-sigmatropic rearrangementsK Araki, W Q Yun, J O'Toole, et al.
Journal of Natural Products|March 16, 2011
New Alkaloid from Schultesia guianensisE M Nóbrega, A A Craveiro, J T Welch, et al.
Journal of Medicinal Chemistry|April 3, 1992
Antimycobacterial activity of a series of pyrazinoic acid estersM H Cynamon, S P Klemens, T S Chou, et al.
International Journal of Pharmaceutics|May 1, 2016
A dry powder combination of pyrazinoic acid and its n-propyl ester for aerosol administration to animalsP G Durham, E F Young, M S Braunstein, et al.
Pharmaceutical Research|June 29, 2016
Inhaled Pyrazinoic Acid Esters for the Treatment of TuberculosisE F Young, E Perkowski, S Malik, et al.
Journal of Medicinal Chemistry|September 29, 1995
Pyrazinoic acid esters with broad spectrum in vitro antimycobacterial activityM H Cynamon, R Gimi, F Gyenes, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Nature Medicine|September 6, 2000
Pyrazinamide inhibits the eukaryotic-like fatty acid synthetase I (FASI) of Mycobacterium tuberculosisO Zimhony, J S Cox, J T Welch, et al.
Carbohydrate Research|October 18, 1993
The synthesis of 2,3-dideoxy-2-fluoro-3-C-methylpentose-containing nucleosides via [3,3]-sigmatropic rearrangementsK Araki, W Q Yun, J O'Toole, et al.
Journal of Natural Products|March 16, 2011
New Alkaloid from Schultesia guianensisE M Nóbrega, A A Craveiro, J T Welch, et al.
Journal of Medicinal Chemistry|April 3, 1992
Antimycobacterial activity of a series of pyrazinoic acid estersM H Cynamon, S P Klemens, T S Chou, et al.
International Journal of Pharmaceutics|May 1, 2016
A dry powder combination of pyrazinoic acid and its n-propyl ester for aerosol administration to animalsP G Durham, E F Young, M S Braunstein, et al.
Pharmaceutical Research|June 29, 2016
Inhaled Pyrazinoic Acid Esters for the Treatment of TuberculosisE F Young, E Perkowski, S Malik, et al.
Journal of Medicinal Chemistry|September 29, 1995
Pyrazinoic acid esters with broad spectrum in vitro antimycobacterial activityM H Cynamon, R Gimi, F Gyenes, et al.
Pageof 3